Crypto presales, once a vibrant avenue for early-stage blockchain projects to secure critical funding, are increasingly starved for capital as the over-the-counter (OTC) market siphons off available liquidity. Investors with limited dry powder are drawn to the OTC market’s promise of immediate access to established tokens, leaving presale project, often speculative and illiquid, struggling to compete. This shift has created a funding dsrought for new ventures, stifling innovation in a space that thrives on fresh ideas.

The choice for investors is stark: OTC markets offer top 100 tokens backed by proven teams, functional products, and tangible traction in users and revenue. In contrast, presales typically involve untested teams pitching unproven concepts with no user base or financial track record and longer vesting to boot. The risk-reward calculus heavily favors OTC’s relative stability, as investors prioritize shorter vesting and credibility over the high-risk gamble of presales, further eroding the presale market’s viability.

